Keratosis linearis with ichthyosis congenita and keratoderma (KLICK) is an autosomal recessive skin disorder associated with a single-nucleotide deletion in the 5′untranslated region of the proteasome maturation protein (POMP) gene. The deletion causes a relative switch in transcription start sites for POMP, predicted to decrease levels of POMP protein in terminally differentiated keratinocytes. To investigate the pathophysiology behind KLICK we created an in vitro model of the disease using siRNA silencing of POMP in epidermal air-liquid cultures. Immunohistochemical analysis of the tissue constructs revealed aberrant staining of POMP, proteasome subunits and the skin differentiation marker filaggrin when compared to control tissue constructs. The staining patterns of POMP siRNA tissue constructs showed strong resemblance to those observed in skin biopsies from KLICK patients. Western blot analysis of lysates from the organotypic tissue constructs revealed an aberrant processing of profilaggrin to filaggrin in samples transfected with siRNA against POMP. Knock-down of POMP expression in regular cell cultures resulted in decreased amounts of proteasome subunits. Prolonged silencing of POMP in cultured cells induced C/EBP homologous protein (CHOP) expression consistent with an activation of the unfolded protein response and increased endoplasmic reticulum (ER) stress. The combined results indicate that KLICK is caused by reduced levels of POMP, leading to proteasome insufficiency in differentiating keratinocytes. Proteasome insufficiency disturbs terminal epidermal differentiation, presumably by increased ER stress, and leads to perturbed processing of profilaggrin. Our findings underline a critical role for the proteasome in human epidermal differentiation.
Citation: Dahlqvist J, Törmä H, Badhai J, Dahl N (2012) siRNA Silencing of Proteasome Maturation Protein (POMP) Activates the Unfolded Protein Response and Constitutes a Model for KLICK Genodermatosis. PLoS ONE 7(1): e29471. doi:10.1371/journal.pone.0029471
Editor: Neil A. Hotchin, University of Birmingham, United Kingdom
Received: May 25, 2011; Accepted: November 29, 2011; Published: January 3, 2012
Copyright: © 2012 Dahlqvist et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Swedish Research Council (K2010-66X-10829-17-3 to N.D.), Uppsala University, Science for Life Laboratory and Uppsala University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
KLICK genodermatosis (MIM #601952) is an autosomal recessive skin disorder characterized by ichthyosis, hyperkeratotic plaques, palmoplantar hyperkeratosis, circular constrictions around fingers and numerous papules in a linear pattern in armfolds and on wrists , , . A single-nucleotide deletion in the 5′ untranslated region (UTR; c.-95DelC) of the POMP gene was recently identified in a homozygous state in patients with KLICK . The mutation is associated with a switch in transcription start sites (TSS's) used for POMP, resulting in a 29-fold increase in the proportion of transcripts with long 5′UTR's in differentiated keratinocytes. Immunohistochemical analysis of skin biopsies from KLICK patients display altered expression of POMP, proteasome subunits and the epidermal differentiation marker filaggrin. Furthermore, differentiated epidermal layers of patient skin biopsies show increased staining of the unfolded protein response (UPR) protein CHOP, suggesting that ER stress is a pathophysiological mechanism in KLICK . However, molecular and cellular studies of keratinocytes with the POMP 5′UTR mutation have been hampered due to difficulties in obtaining terminally differentiated keratinocytes in vitro.
The proteasome is a large protein complex, step-wise assembled by α and β subunits forming hemiproteasomes which dimerize to form a complete proteasome , . POMP is essential for the incorporation of β subunits, the dimerization of hemiproteasomes and consequently for normal proteasome function , . However, the direct impact of a deficient POMP function on proteasome α and β subunit levels has not been thoroughly investigated. Under physiological conditions misfolded and folding-incompetent proteins in the ER are retrotranslocated to the cytoplasm, polyubiquitinated and degraded by the proteasome . It is known that inhibition of the proteasome impedes ER function and induces ER stress, but whether POMP insufficiency has the same consequences is unknown , . ER stress activates the UPR, a cellular response to restore ER homeostasis. As proteins accumulate in the ER, the chaperone BiP dissociates from ER transmembrane receptors, which then induce different UPR pathways aiming to attenuate protein translation, induce expression of ER and UPR factors and increase protein degradation , , , .
In this study we present additional evidence for an association between decreased amounts of POMP, increased ER stress and KLICK genodermatosis. We show that in vitro knock-down of POMP expression in organotypic epidermal tissue constructs mimics the immunohistochemical phenotype of KLICK epidermis in terms of aberrant POMP, filaggrin and proteasome subunit distribution. Silencing of POMP expression in cell culture results in decreased amounts of proteasome subunits and increased ER stress. These results underline the importance of proteasomes in epidermal differentiation and link ER stress to aberrant epidermal differentiation in KLICK genodermatosis.
Long mutant 5′ UTR shows a strong tendency for reducing POMP translation efficiency
We have previously shown in overexpression studies that a long POMP wild type 5′ UTR reduces POMP-GFP fusion protein levels compared to short 5′ UTR POMP constructs . To investigate the effects of a long 5′ UTR including the KLICK-associated variant c.-95delC in comparison to a short wild type 5′ UTR on POMP protein expression we overexpressed two constructs containing full-length POMP cDNA with different 5′ UTR's; one with an 81-nt-5′ UTR, wild type, and one with a 181-nt-5′ UTR including c.-95DelC. The constructs were fused with GFP and transiently expressed in HeLa and HaCaT cells. Western blot analysis revealed a 23% reduction in POMP-GFP expression from the mutant 181-nt-5′UTR construct compared to the wild type 81-nt-5′UTR construct in HeLa cells (One-Sample (OS) t-test p = 0.0801, Mann-Whitney (MW) p = 0.0636) and a 31% reduction in HaCaT cells (OS t-test p = 0.0894, MW p = 0.0636; Fig. 1).
Fusion protein levels of POMP-GFP were measured by western blot analysis of cells transfected with POMP-GFP constructs (right panel). Two different variants of POMP cDNA were analyzed, differing in their 5′ UTR: one clone had an 81-nt-5′ UTR, wild type, and one clone had a 181-nt-5′ UTR with mutation c.-95delC. Fusion protein levels of 181-nt-5′ UTR c.-95delC constructs are plotted as relative expression from the 81-nt-5′ UTR construct. Results are based on three separate experiments and are presented as mean values +/− standard deviation (SD). Fusion protein levels were related to GFP levels of co-transfected empty vectors and to GAPDH as internal control.
POMP siRNA transfected epidermal tissue constructs mimic KLICK epidermis
Next, we investigated whether siRNA silencing of POMP expression in keratinocyte air-liquid cultures can function as a model of KLICK in vitro. Cells transfected with POMP siRNA or mock siRNA as well as non-transfected cells were cultured for 10–12 days on polycarbonate inserts. Subsequent mRNA analysis showed an average reduction in POMP transcript levels of 54% and 53% in POMP siRNA transfected tissue constructs compared to mock siRNA transfected and non-transfected tissue constructs, respectively (data not shown). Sections of the tissue constructs were analyzed together with skin biopsies derived from healthy controls and KLICK patients  by immunohistochemical staining of POMP and proteasome subunits α7 and β5. POMP-silenced organotypic epidermis showed a weak staining of POMP and a weak and patchy staining of α7 proteasome subunits compared to non-transfected and mock-transfected tissue cultures (Fig. 2 A–B), whilst the staining of β5 proteasome subunits was similar between all tissue constructs (Fig. 2 C). The staining patterns of proteasome subunits in POMP-silenced organotypic epidermis are in almost complete agreement with those observed in skin biopsies from KLICK patients using the same antibodies .
Epidermal tissue constructs were established without transfection and after transfection with POMP siRNA or mock siRNA. Sections of the mature tissue constructs were immunostained with (A) anti-POMP, (B) anti-α7 proteasome subunit and (C) anti-β5 proteasome subunit antibodies. POMP siRNA transfected tissue cultures showed POMP mRNA levels reduced to 46% of the levels in mock transfected cells. Results are based on three separate experiments. Bar: 20 µm.
POMP deficiency disrupts epidermal profilaggrin processing
Next, we stained sections from the epidermal tissue constructs with antibodies against filaggrin. We observed a weak and patchy staining of the cornified cell layer of POMP-silenced organotypic epidermis, compared to control sections (Fig. 3 A). Again, these staining patterns are in agreement with those of skin from KLICK patients and healthy controls, respectively . Filaggrin derives from the precursor protein profilaggrin, which consists of an N-terminal domain, followed by a truncated filaggrin unit, 10–12 complete filaggrin units and a C-terminal domain. Profilaggrin is proteolytically cleaved into its subunits in differentiated epidermis . To investigate whether the expression and proteolytic processing of profilaggrin is affected by POMP deficiency we stained skin sections from healthy controls and KLICK patients and sections from the epidermal tissue constructs with antibodies against the N-terminal domain of profilaggrin. The immunostaining of healthy skin was confined to the outermost cells of the granular cell layer and the innermost cells of the cornified layer (Fig. S1 A) whereas sections from KLICK patients showed an irregular staining of the same cell layers and, additionally, a patchy staining of the entire cornified layer with preserved granules of profilaggrin in the outermost cells (Fig. S1 B–C). Sections from POMP-silenced epidermal tissue constructs showed a reduced immunostaining of the granular cell layer when compared to the non-transfected and mock siRNA transfected epidermal tissue constructs (Fig. 3 B). Similar to what was observed in skin from KLICK patients the POMP siRNA treated tissue constructs also showed a retention of profilaggrin granules in the cornified cell layer (Fig. 3 B). To verify that POMP deficiency perturbs profilaggrin processing, lysates from the organotypic constructs were analyzed by western blot and immunodetection of the N-terminal domain of profilaggrin. Interestingly, the cleaved N-terminal domain (32–33 kDa) was not detected in lysates from POMP siRNA transfected constructs but clearly observed in lysates from non-transfected and mock siRNA transfected tissue constructs (Fig. 3 C).
Epidermal tissue constructs were established without transfection and after transfection with mock siRNA or POMP siRNA, respectively. Sections of the mature tissue constructs were immunostained with (A) anti-filaggrin (Novocastra) and (B) anti-profilaggrin antibodies (Abcam). Magnification: ×63. (C) Lysates was prepared from the three epidermal tissue constructs and analyzed using western blot analysis with immunodetection of the N-terminus of profilaggrin. Predicted profilaggrin cleavage products (N-terminal domain (32 kDa) and N-terminal domain with truncated filaggrin unit (55–57 kDa)) are indicated by arrows, respectively (upper panel). GAPDH was used as internal control. Results are based on three separate experiments. Non-transf. = non-transfected tissue construct; mock siRNA = mock siRNA transfected tissue construct; POMP siRNA = POMP siRNA transfected tissue construct.
Silencing of POMP expression in cultured cells causes a decrease in proteasome subunit levels
We next wanted to elucidate the direct effects of absent POMP on α and β proteasome subunits, by silencing POMP expression in HeLa and HaCaT cells. Cells transfected with mock siRNA, non-transfected cells and non-transfected cells treated with proteasome inhibitor MG132 were used for comparison. POMP siRNA reduced POMP mRNA levels to 8.0% (HeLa) and 5.6% (HaCaT) of levels in mock transfected cells at 48 h after transfection and to 5.7% (HeLa) and 6.9% (HaCaT) at 72 h after transfection (Fig. S2 A–B). There were no measurable levels of POMP protein after 48 h or 72 h in either of the two POMP siRNA transfected cell types (Fig. 4 A–C). mRNA and protein levels of proteasome subunits α7 and β5 were first measured at 48 h after transfection. Decreased levels of α7 protein were observed in HaCaT cells (t-test p = 0.000386, MW p = 0.1) and a tendency for a decrease in α7 and β5 levels was seen in HeLa cells (α7 t-test p = 0.0860, MW p = 0.1; β5 t-test p = 0.0696, MW p = 0.2; Fig. 4 A–B), whilst the mRNA levels were mainly unaffected (Fig. S2 A). At 72 h after transfection β5 protein levels were reduced in both cell types (HeLa t-test p = 0.0220, MW p = 0.1; HaCaT t-test p = 0.0400, MW p = 0.1; Fig. 4 A, C) whereas mRNA levels of both α7 and β5 were increased in both cell types (HeLa α7 t-test p = 0.00539, MW p = 0.1, β5 t-test p = 0.0243, MW p = 0.1; HaCaT α7 t-test p = 0.0444, MW p = 0.1, β5 t-test p = 0.0265, MW p = 0.1; Fig. S2 B) compared to mock transfected cells. MG132 treated cells showed an increase in α7, β5 and POMP mRNA and in POMP protein levels, as described previously .
Crude lysates were prepared from HeLa and HaCaT cells transfected with POMP siRNA or mock siRNA and non-transfected cells (+/−1 µM MG132). Western blot analyses were run for POMP and proteasome subunits α7 and β5 at 48 h (A, B) and 72 h (A, C) post transfection. Results are based on three separate experiments and are presented as mean values +/− SD. GAPDH was used as internal control. Protein levels of siRNA transfected and MG132 treated cells were normalized against non-transfected cells. Differences between POMP siRNA and mock siRNA transfected cells were analyzed using Student's t-test; * = p<0.05, *** = p<0.001.
Silencing of POMP expression in cultured cells activates the UPR
Proteasome inhibitors are known to induce the UPR ,  and lead us to investigate whether a similar effect could be observed in cells depleted of POMP. mRNA and protein levels of ER chaperone BiP and UPR transcription factors ATF4 and CHOP were analyzed in cells transfected with siRNA against POMP. At 48 h after transfection an increase in BiP protein levels was observed in HaCaT (t-test p = 0.0352, MW p = 0.1) but not in HeLa cells (Fig. 5 A–B). None of the two cell types showed any significant changes in ATF4 levels or measurable levels of CHOP proteins and there were no changes in BiP, ATF4 or CHOP mRNA levels (Fig. S2 C). At 72 h after transfection of POMP siRNA CHOP protein was expressed in both HeLa and HaCaT cells (HeLa t-test p = 0.142, MW p = 0.631, HaCaT t-test p = 4.89*10−5, MW p = 0.0636) in three out of three experiments, while there were no changes in BiP or ATF4 levels (Fig. 5 A–C). A very weak detection of CHOP was observed in one western blot experiment for mock transfected and non-transfected cells respectively. CHOP mRNA levels were increased in HeLa cells (t-test p = 0.0275, MW p = 0.1) and BiP mRNA was increased in HaCaT cells (t-test p = 0.0359, MW 0.1; Fig. S2 D). MG132 treated cells showed increased mRNA levels for all three UPR markers in accordance with previous studies ,  while protein measurements revealed an increase in CHOP.
Crude lysates were prepared from HeLa and HaCaT cells transfected with POMP siRNA or mock siRNA and non-transfected cells (+/−1 µM MG132). Western blot analyses were run for UPR markers BiP, ATF4 and CHOP at 48 h (A, B) and 72 h (A, C) post transfection. Results are based on three separate experiments and are presented as mean values +/− SD. GAPDH was used as internal control. BiP and ATF4 protein levels of siRNA transfected and MG132 treated cells were normalized against non-transfected cells. Differences between POMP siRNA and mock siRNA transfected cells were analyzed using Student's t-test; * = p<0.05, *** = p<0.001.
Terminal differentiation of human epidermis requires a network of cooperating events, involving complex and spatial assembly and degradation of proteins and lipids . We have previously reported on aberrant epidermal differentiation in patients with KLICK genodermatosis . Affected individuals are homozygous for a single-nucleotide deletion in the 5′ UTR of the POMP gene. The mutation is associated with a transcriptional switch towards POMP transcripts with long 5′ UTRs, particularly in differentiated keratinocytes where long 5′ UTR transcripts constitute 83% of all POMP transcripts in patients but only 2.6% in controls . Skin biopsies from KLICK patients show abnormal distribution of proteasomes as well as an indication of increased UPR. We present herein evidence for a disturbed keratinocyte differentiation due to POMP insufficiency which emphasizes the importance of the proteasome system in terminal epidermal differentiation. In addition, POMP depleted cells show an activated UPR, providing further support for the hypothesis of ER stress as an important pathophysiological mechanism in KLICK.
Transcripts with long 5′ UTR's are generally associated with reduced translation rate . We were, despite this, unable to detect decreased POMP protein levels in cultured keratinocytes from KLICK patients in our previous study . In the present study we hypothesized that the effect of an increased proportion of POMP transcripts with long 5′ UTR on translational efficiency is detectable only in terminally differentiated keratinocytes. To clarify the role of 5′ UTR length and the single-nucleotide deletion on POMP translation we over-expressed POMP constructs with different length of the 5′ UTR, in two different cell types. We found that constructs expressing a long 5′ UTR (181 nt) with the KLICK mutation produce 23–31% less protein than shorter 5′ UTR (81 nt) constructs. These findings indicate that KLICK patients, predominantly expressing long 5′UTR POMP transcripts in differentiated keratinocytes, have a decreased POMP translation rate in differentiated epidermis.
We next wanted to ensure that reduced POMP protein levels cause the abnormal epidermal differentiation seen in KLICK skin , using epidermal tissue constructs as an in vitro model of human interfollicular epidermis . The constructs mimic the stratification of cells into basal, spinous, granular and cornified layers, but the thickness of different layers may differ from epidermis due to the humidity and culture time of the air-liquid systems, as well as the lack of mechanical stress. We established epidermal tissue constructs in air-liquid culture systems pre-transfected with siRNA against POMP. Interestingly, after 10–12 days we observed an aberrant staining of POMP and proteasome subunit α7 in siRNA transfected tissue constructs where the patchy staining of α7 resembles that of KLICK skin biopsies. This indicates that the deviations observed in KLICK skin are specific effects of POMP insufficiency and a disturbed proteasome function. Moreover, the incoherent staining of profilaggrin and filaggrin in KLICK skin was apparent also in POMP siRNA transfected tissue constructs. Although the expression of profilaggrin in tissue constructs seems to be reduced when compared to skin of KLICK patients, we observe a clear effect on profilaggrin processing associated with POMP deficiency. Western blot analysis of the N-terminus of profilaggrin revealed an aberrant pattern with absence of the N-terminal cleavage product of profilaggrin comprising the profilaggrin A and B domains , ,  in POMP-silenced tissue constructs. In combination, these findings indicate that the proteasome is involved in profilaggrin processing and that KLICK is associated with a disturbed epidermal expression of filaggrin.
From our results we concluded that siRNA silencing of POMP models KLICK syndrome in vitro. We then studied the effects of knock-down of POMP in regular cell cultures. It has previously been shown that silencing of POMP expression by siRNA results in abolished incorporation of β5 and β5i subunits into proteasomes and hence a decreased amount of mature proteasomes , . In support of this we observed decreased amounts of α7 proteasome subunits in HaCaT cells at 48 h post siRNA transfection and decreased levels of β5 subunits in both HaCaT and HeLa cells at 72 h post transfection. The results imply that reduced POMP levels lead to degradation of free subunits, with cell type specific differences in response time between α7 and β5 subunits. The reduction in amounts of subunit proteins was associated with a compensatory transcriptional up-regulation of α7 and β5 subunit genes. The effect of POMP knock-down on proteasome subunits explains the weaker expression of α7 and β5 in KLICK epidermis. Interestingly, there was no decrease in α7 and β5 subunits in cells treated with the proteasome inhibitor MG132, indicating that the subunits remain stable if proteasomes are inhibited at a mature stage.
Proteasome degradation and the UPR are tightly regulated and connected systems of critical importance for the cell. The systems relieve the ER from protein overload, e.g. related to protein misfolding, high protein production or defect protein degradation , . Keratinocytes of the granular epidermal layer are highly protein secreting cells with a physiological ER stress and active UPR , . This makes keratinocytes vulnerable for a compromised ER function as shown for UVB exposed epidermis and in erythrokeratoderma variabilis , . We analyzed ER chaperone BiP and UPR markers CHOP and ATF4 in cells depleted of POMP after siRNA transfection. We found a significant up-regulation of CHOP after prolonged (72 h) knock-down of POMP in both HeLa and HaCaT cells. CHOP is generally not expressed under physiological conditions, but is activated at later stages of the UPR  consistent with the expression in our experiments. Furthermore, POMP knock-down caused a slight increase in the ER chaperone BiP in keratinocyte derived HaCaT cells, but not in HeLa cells, supporting tissue specific sensitivity to ER stress, as suggested previously . No changes were seen in ATF4 levels for either of the cell types. Levels of BiP and ATF4 increase early in the UPR ,  and we cannot exclude that marked changes in levels of these proteins take place before 48 h.
Taken together, we show that the POMP 5′ UTR mutation associated with KLICK genodermatosis results in reduced POMP expression, which in turn causes reduced levels of proteasome subunits and filaggrin as well as increased ER stress. Our results are consistent with different possible mechanisms contributing to perturbed epidermal differentiation in KLICK genodermatosis: Firstly, the cleavage products of profilaggrin have been shown to be indispensable in the formation of the epidermal water barrier ,  and we show that the proteasome is essential for adequate profilaggrin processing. Secondly, the proteasome is a known regulator of key proteins in several cellular processes and has, for instance, been shown to control the levels of retinoic acid receptor gamma, which is important for transcriptional regulation in epidermis . Thirdly, aggregation of unfolded proteins hampers normal cellular processes and the UPR has been shown to directly affect the expression of genes involved in epidermal differentiation , .
Further studies are required to clarify the exact role of the proteasome in epidermal differentiation and the molecular effects of increased ER stress in epidermis. Increased understanding of ER stress involvement in KLICK genodermatosis and epidermal differentiation may open up for new therapeutic strategies of potential importance for a large group of skin disorders.
Materials and Methods
This project was approved by the local Research Ethics Committee Uppsala. The use of human samples is conducted according to the principles expressed in the Declaration of Helsinki.
HeLa cells  were cultured in RPMI 1640 with 10% Fetal bovine serum (FBS), 100 U/ml Penicillin-Streptomycin (PEST) and 2 mM L-glutamine (all GIBCO/Invitrogen, Paisley, UK). The HaCaT keratinocyte cell line  was cultured in calcium-free DMEM (Invitrogen) with 10% chelexed FBS, 100 U/ml PEST, 2 mM L-glutamine and supplement of 0.03 mM CaCl2. All cells were cultured in 37 degrees Celsius with 5% CO2 in a humid environment.
For air-liquid cultures we used second to third passage epidermal keratinocytes expanded in EpiLife™ medium (Invitrogen) that were seeded the day after siRNA transfection on Millicell-PCF inserts (pore size 0.4 µm; Millipore AB, Solna, Sweden) at a density of 3×105 cells/insert in 1.5 mM CaCl2 supplemented medium. The keratinocytes were cultured as described previously  for 10–12 days after which punch biopsies were taken from the tissue constructs for analysis by immunohistochemistry and quantitative real-time PCR.
Cloning and transfection of reporter constructs
cDNA clones corresponding to two variants of full length POMP cDNA were cloned into a fluorescent reporter vector (pAcGFP1-N1; Clontech, Saint-Germain-en-Laye, France) to produce POMP-GFP fusion proteins, as described previously . The two clone variants differ in their 5′ UTR: one clone corresponds to wild type POMP transcripts with an 81-nucleotide 5′ UTR (81-wt-5′UTR) and one clone is associated with KLICK genodermatosis having a 181-nucleotide 5′ UTR with a cytosine deletion (c.-95DelC). All plasmids were verified by sequencing. HeLa and HaCaT cells were transfected with either of the POMP-GFP vectors together with empty vector using Lipofectamine 2000 (Invitrogen) according to the manufacturer's recommendations. Cells were harvested after 48 hours by trypsinization for protein preparation. Statistical calculations were performed with results from three experiment replicates using both One-sample t-test (OS; to give an indication of significance of differences between samples) and Mann-Whitney's test (MW; due to the low number of observations), using R software.
For silencing of POMP expression Invitrogen Stealth Select RNAi™ siRNA (oligo ID: HSS147436, HSS147437) was used. Cultured keratinocytes, HeLa and HaCaT cells were transfected with POMP siRNA using Lipofectamine RNAiMax (Invitrogen) according to the protocol provided by the manufacturer. HeLa and HaCaT cells were harvested at 48 h and 72 h after transfection for RNA and protein preparation. The two siRNA oligos worked equally well with a 92.0–94.4% reduction of POMP expression in HeLa and HaCaT experiments. Cells transfected with negative control (mock) siRNA (Stealth RNAi™ siRNA Negative Control LO GC, HI GC; Invitrogen), non-transfected cells and non-transfected cells treated with 1 µM proteasome inhibitor MG132 (Sigma Aldrich, St Louis, MS, US) for 20 h were used as negative and positive controls respectively. mRNA and protein analyses of POMP siRNA and mock siRNA transfected samples were performed with results from three separate experiments using Student's t-test and MW. Air-liquid cultures were set up in triplicates in three separate experiments and mock siRNA transfected and non-transfected cells were used as controls.
Western blot analysis
HeLa and HaCaT cells were harvested by trypsinization and were after centrifugation resuspended in RIPA buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate and 0.1% SDS; supplemented with MG132 proteasome inhibitor, phosphatase inhibitor cocktail 1, 0.1 mM sodium vanadate and protease inhibitor cocktail (all from Sigma Aldrich)) and kept at +4 degrees Celsius for 1 hour for protein preparation. The cell suspension was centrifuged for 10 min at +4 degrees Celsius at 13000 rpm to remove cell debris and the lysate was stored at −70 degrees Celsius until use . Lysates were separated on Bis-Tris SDS-PAGE gels (Invitrogen), transferred to PVDF membranes (Millipore) and incubated with primary and secondary antibodies as described previously . Secondary antibodies were conjugated with Alexa Fluor 680 (anti-mouse; Molecular probes/Invitrogen) or IRDye 800 (anti-rabbit; Li-Cor Bioscience, Cambridge, UK) for visualization with Odyssey infrared imaging system® (Li-Cor Bioscience). Immunodetection of target proteins was performed with anti-POMP, anti-α7 proteasome subunit, anti-β5 proteasome subunit (all BIOMOL, Hamburg, Germany), anti-CHOP (Cell Signaling technologies, Danvers, MA, US; Santa Cruz, Santa Cruz, CA, US), anti-BiP (Santa Cruz) and anti-ATF4 (Abcam, Cambridge, UK) antibodies for the siRNA experiments and anti-GFP (Clontech) antibody for the construct experiments. GADPH (Abcam) was used as internal control for all experiments and POMP-GFP fusion protein levels were adjusted for transfection efficiency by normalization against levels of co-transfected empty vector (pAcGFP1-N1). Western blot experiments for detection of profilaggrin degradation products in epidermal tissue constructs were performed similarly with tissue constructs lysed in RIPA buffer and antigens detected using anti-filaggrin antibodies (Abcam; ab81468 ) targeting the profilaggrin N-terminal domain.
Quantitative real-time PCR
Total RNA was extracted from cultured HeLa and HaCaT cells and epidermal tissue constructs using Trizol (Invitrogen). The RNA was treated with DNase I (Sigma Aldrich) and reverse transcribed with RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentas, Helsingborg, Sweden). Quantitative real-time PCR (qPCR) was run using Platinum SYBR Green qPCR supermix-UGD kit (Invitrogen) as described previously , with cDNA primers ordered from Sigma Aldrich (Table 1) and target gene expression levels normalized to beta actin levels.
Epidermal tissue contructs were cut into 6 µm sections for protein visualization using primary antibodies against POMP (Abcam), α7 proteasome subunit, β5 proteasome subunit (both BIOMOL),filaggrin (Novocastra, Kista, Sweden) and profilaggrin (Abcam; targeting the profilaggrin N-terminal domain). The same antibody was used for immunohistochemical detection of profilaggrin on sections from skin biopsies from four healthy controls and three KLICK patients. Sections were fixed in 100% ice cold acetone and endogenous peroxidase activity was blocked by Peroxidazed 1 (Biocare Medical, Concord, CA, US). After reaction with Background Sniper (Biocare Medical) and incubation with primary antibodies, sections were incubated with biotinylated secondary antibodies (Vector Laboratories, Burlingame, CA, US). Thereafter the skin sections were incubated with avidin-biotin complex (Vector Laboratories) or Mach 3 Rabbit HRP polymer Detection Kit (Biocare Medical) for β5 subunit and peroxidase reactions were developed with DAB (Vector Laboratories). Filaggrin stained sections were counterstained with hematoxylin. Image analysis was performed with Leica DLMB microscope and Leica QWin software.
Immunohistochemical detection of profilaggrin in human skin. Epidermal sections from an healthy control (A) and patients with KLICK syndrome (B, C) were stained with antibodies against profilaggrin (Abcam). (C) Magnification of the cornified cell layer of patient epidermis. Bar: 50 µm.
mRNA analysis of POMP siRNA transfected cell lines. POMP was silenced in HeLa and HaCaT cells by siRNA transfection and cells transfected with mock siRNA and cells without transfection (+/−1 µM MG132) were used for comparison. mRNA levels of POMP, α7, β5 (A–B), BiP, ATF4 and CHOP (C–D) were analyzed by qPCR at 48 h (A, C) and 72 h (B, D) post transfection. Beta actin was used as internal control. Differences between POMP siRNA and mock siRNA transfected cells were analyzed using Student's t-test; * = p<0.05, *** = p<0.001.
We thank Anders Vahlquist and Maurice van Steensel for valuable discussions and comments, Inger Pihl-Lundin for immunohistochemical work and Hao Li for technical support.
Conceived and designed the experiments: JD HT JB. Performed the experiments: JD JB. Analyzed the data: JD HT ND. Contributed reagents/materials/analysis tools: JD HT ND. Wrote the paper: JD ND.
- 1. Pujol RM, Moreno A, Alomar A, de Moragas JM (1989) Congenital ichthyosiform dermatosis with linear keratotic flexural papules and sclerosing palmoplantar keratoderma. Arch Dermatol 125: 103–106.
- 2. Vahlquist A, Ponten F, Pettersson A (1997) Keratosis linearis with ichthyosis congenita and sclerosing keratoderma (KLICK-syndrome): a rare, autosomal recessive disorder of keratohyaline formation? Acta Derm Venereol 77: 225–227.
- 3. van Steensel MA, van Geel M, Steijlen PM (2005) A new type of erythrokeratoderma. Br J Dermatol 152: 155–158.
- 4. Dahlqvist J, Klar J, Tiwari N, Schuster J, Torma H, et al. (2010) A single-nucleotide deletion in the POMP 5′ UTR causes a transcriptional switch and altered epidermal proteasome distribution in KLICK genodermatosis. Am J Hum Genet 86: 596–603.
- 5. Hirano Y, Hendil KB, Yashiroda H, Iemura S, Nagane R, et al. (2005) A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes. Nature 437: 1381–1385.
- 6. Hirano Y, Kaneko T, Okamoto K, Bai M, Yashiroda H, et al. (2008) Dissecting beta-ring assembly pathway of the mammalian 20S proteasome. EMBO J 27: 2204–2213.
- 7. Heink S, Ludwig D, Kloetzel PM, Kruger E (2005) IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A 102: 9241–9246.
- 8. Fricke B, Heink S, Steffen J, Kloetzel PM, Kruger E (2007) The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum. EMBO Rep 8: 1170–1175.
- 9. Meusser B, Hirsch C, Jarosch E, Sommer T (2005) ERAD: the long road to destruction. Nat Cell Biol 7: 766–772.
- 10. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13: 1211–1233.
- 11. Wu WK, Sakamoto KM, Milani M, Aldana-Masankgay G, Fan D, et al. (2010) Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resist Updat 13: 87–92.
- 12. Naidoo N (2009) ER and aging-Protein folding and the ER stress response. Ageing Res Rev 8: 150–159.
- 13. Ma Y, Brewer JW, Diehl JA, Hendershot LM (2002) Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J Mol Biol 318: 1351–1365.
- 14. Chiribau CB, Gaccioli F, Huang CC, Yuan CL, Hatzoglou M (2010) Molecular symbiosis of CHOP and C/EBP beta isoform LIP contributes to endoplasmic reticulum stress-induced apoptosis. Mol Cell Biol 30: 3722–3731.
- 15. Malhotra JD, Kaufman RJ (2007) The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 18: 716–731.
- 16. Sandilands A, Sutherland C, Irvine AD, McLean WH (2009) Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 122: 1285–1294.
- 17. Meiners S, Heyken D, Weller A, Ludwig A, Stangl K, et al. (2003) Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes. J Biol Chem 278: 21517–21525.
- 18. Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, et al. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107: 4907–4916.
- 19. Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, et al. (2007) Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 171: 513–524.
- 20. Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17: 1063–1072.
- 21. Pickering BM, Willis AE (2005) The implications of structured 5′ untranslated regions on translation and disease. Semin Cell Dev Biol 16: 39–47.
- 22. Poumay Y, Dupont F, Marcoux S, Leclercq-Smekens M, Herin M, et al. (2004) A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res 296: 203–211.
- 23. List K, Szabo R, Wertz PW, Segre J, Haudenschild CC, et al. (2003) Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163: 901–910.
- 24. Presland RB, Kimball JR, Kautsky MB, Lewis SP, Lo CY, et al. (1997) Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J Invest Dermatol 108: 170–178.
- 25. Sugiura K, Muro Y, Futamura K, Matsumoto K, Hashimoto N, et al. (2009) The unfolded protein response is activated in differentiating epidermal keratinocytes. J Invest Dermatol 129: 2126–2135.
- 26. Maytin EV, Habener JF (1998) Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110: 238–246.
- 27. Tattersall D, Scott CA, Gray C, Zicha D, Kelsell DP (2009) EKV mutant connexin 31 associated cell death is mediated by ER stress. Hum Mol Genet 18: 4734–4745.
- 28. Anand S, Chakrabarti E, Kawamura H, Taylor CR, Maytin EV (2005) Ultraviolet light (UVB and UVA) induces the damage-responsive transcription factor CHOP/gadd153 in murine and human epidermis: evidence for a mechanism specific to intact skin. J Invest Dermatol 125: 323–333.
- 29. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, et al. (2006) Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38: 337–342.
- 30. Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ (2000) Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res 60: 2247–2252.
- 31. Nemes Z, Marekov LN, Fesus L, Steinert PM (1999) A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci U S A 96: 8402–8407.
- 32. Gey GO, Coffman WD, Kubicek MT (1952) Tissue culture studies on the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Research 12: 264–265.
- 33. Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, et al. (2009) Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children. Br J Dermatol 161: 884–889.
- 34. Badhai J, Frojmark AS, Razzaghian HR, Davey E, Schuster J, et al. (2009) Posttranscriptional down-regulation of small ribosomal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency. FEBS Lett 583: 2049–2053.
- 35. Melin M, Klar J Jr, Gedde-Dahl T, Fredriksson R, Hausser I, et al. (2006) A founder mutation for ichthyosis prematurity syndrome restricted to 76 kb by haplotype association. J Hum Genet 51: 864–871.